Romano Sarah - Insider Non-Derivative Transactions at Entero Therapeutics, Inc. (ENTO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 6, 2025, Romano Sarah's relationship to Entero Therapeutics, Inc. (ENTO) is Officer (Chief Financial Officer), and currently has 17,287 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ENTO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Romano Sarah - Insider Non-Derivative Transactions of ENTO Common Stock

Romano Sarah - Insider Non-Derivative Transactions at ENTO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 7, 2025	Sell -- (Common Stock)	727	0.64	17287
Oct 10, 2024	Sell -- (Common Stock)	476	0.45	18014
Jul 3, 2024	Sell -- (Common Stock)	621	1.07	18490